Beardsley Robert A bought ABUS
June 8, 2026 · Form 4 insider transaction
Beardsley Robert A bought 78,800 shares of Arbutus Biopharma Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
78,800
Price
$0.00
Total value
N/A
InsiderBeardsley Robert A
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 8, 2026
Filing dateJune 10, 2026
Shares owned after78,800
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.; The option is fully vested and exercisable as of the date of the grant.